Contact information for researchers and applicants
Grant Management Team
If you have any questions, please contact our Grant Management Team. They are happy to help you with the administrational procedures regarding your grant application or current research project. They can also refer you to one of our Science Liaisons who supervise our research projects by research theme.
- T: +31 20 - 570 04 50
- KWF Helpdesk
Science Liaison Team
Jasmijn Span, MSc - Basic Research
Scientific research aimed at obtaining insight into the origin and progression of cancer, its (psychosocial) effects, as well as basic principles of prevention and treatment of cancer and relevant technological developments. Basic research does not directly focus on the possible application of this knowledge.
Jet Segeren, PhD - Basic Research
Scientific research aimed at obtaining insight into the origin and progression of cancer, its (psychosocial) effects, as well as basic principles of prevention and treatment of cancer and relevant technological developments. Basic research does not directly focus on the possible application of this knowledge.
Bram ter Ellen, PhD - Biomarkers
Biomarkers are characteristics that are objectively measured and evaluated as an indicator for cancer risk, the presence of a specific cancer or recurrent cancer, the stage or severity of a specific cancer, and how well the patient responds to therapeutic intervention(s).
Sigrid Oomen, PhD - Interventive Devices
Treatment instruments to prevent or treat local-regional sites of cancer or precancerous lesions. The modalities may be delivered non-invasively (e.g. radiation therapy), minimally invasively (e.g.cryoablation, hyperthermia) or by open surgery (invasive).
Carrie Wismans, MSc - Imaging
Scientific research into imaging includes various types of techniques to obtain detailed pictures of areas inside the body, such as magnetic fields (MRI), X-rays (CT), ultrasound (echography) and radioactive substances (PET) for functional imaging. Imaging is used to detect early stage cancer, diagnose disease, plan treatment or assess therapeutic response.
Céline Sewnath, PhD - Agents (pre-clinical)
Drugs or biologicals used to prevent or inhibit the proliferation of cancerous cells. Examples of agents are small molecules, therapeutic enzymes and hormones.
Esther Dalhuisen-Suurland, MSc - Agents (clinical)
Drugs or biologicals used to prevent or inhibit the proliferation of cancerous cells. Examples of agents are small molecules, therapeutic enzymes and hormones.
Kim Elsink, MSc - Infrastructure
Infrastructural initiatives provide services, resources and networks to support cancer research. These initiatives enable the research community to address specific research questions and thereby help accelerate and/or optimise the exploitation of results to the patients and public.
Fiona Heeman, PhD - Quality of Life & Care
Quality of life encompasses all aspects of well-being, including functional, social, societal, psychological, emotional and existential problems in (ex)patients and their caregivers. Quality of care is aimed at providing the most appropriate oncological care according to the needs of each individual patient, developing and implementing national best practice guidelines and improving healthcare communication.
